Abstract
Metabolic reprogramming is a hallmark of cancer. Altered metabolism provides a survival advantage for cancer cells during tumorigenesis by supplying resources needed for uncontrolled growth and increased rates of cell division. As tumors grow beyond the limits of diffusion, altered metabolism provides a selective advantage in the context of nutrient deprivation. Many cancer therapies, including radiation, are known to impact tumor metabolism while the metabolic state of a cancer may contribute to radioresistance. Preclinical and clinical evidence exists to support combinations of radiation therapy with drugs that affect, for example, oxidative, glucose, glutamine, one-carbon, nucleotide, or iron metabolism in cancers. Work is ongoing to determine optimal strategies for combining these drugs with conventionally fractionated and hypofractionated radiation schemes. New strategies, including dietary manipulation during the course of radiation therapy, are currently being explored. Targeting tumor metabolism is a rapidly evolving and promising field of oncology and will be reviewed here in more detail.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, Scheck AC (2012) The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One 7(5):e36197. https://doi.org/10.1371/journal.pone.0036197
Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, Halverson RC, Simper SC, Hopkins PN, Hunt SC (2009) Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) 17(4):796–802. https://doi.org/10.1038/oby.2008.610
Ahmad IM, Aykin-Burns N, Sim JE, Walsh SA, Higashikubo R, Buettner GR, Venkataraman S, Mackey MA, Flanagan SW, Oberley LW, Spitz DR (2005) Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. J Biol Chem 280(6):4254–4263. https://doi.org/10.1074/jbc.M411662200
Alberghina L, Gaglio D (2014) Redox control of glutamine utilization in cancer. Cell Death Dis 5:e1561. https://doi.org/10.1038/cddis.2014.513
Alexander MS, Wilkes JG, Schroeder SR, Buettner GR, Wagner BA, Du J, Gibson-Corley K, O'Leary BR, Spitz DR, Buatti JM, Berg DJ, Bodeker KL, Vollstedt S, Brown HA, Allen BG, Cullen JJ (2018) Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer. Cancer Res 78(24):6838–6851. https://doi.org/10.1158/0008-5472.CAN-18-1680
Allegra CJ, Chabner BA, Drake JC, Lutz R, Rodbard D, Jolivet J (1985a) Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. J Biol Chem 260(17):9720–9726
Allegra CJ, Drake JC, Jolivet J, Chabner BA (1985b) Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. Proc Natl Acad Sci U S A 82(15):4881–4885. https://doi.org/10.1073/pnas.82.15.4881
Allen AM, Czerminska M, Janne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH (2006) Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65(3):640–645. https://doi.org/10.1016/j.ijrobp.2006.03.012
Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore JM, Sibenaller ZA, Mapuskar KA, Schoenfeld JD, Buatti JM, Spitz DR, Fath MA (2014) Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism. Redox Biol 2:963–970. https://doi.org/10.1016/j.redox.2014.08.002
Allen BG, Bhatia SK, Buatti JM, Brandt KE, Lindholm KE, Button AM, Szweda LI, Smith BJ, Spitz DR, Fath MA (2013) Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin Cancer Res 19(14):3905–3913. https://doi.org/10.1158/1078-0432.CCR-12-0287
Allen BG, Bodeker KL, Smith MC, Monga V, Sandhu S, Hohl RJ, Carlisle TL, Brown HA, Hollenbeck NJ, Vollstedt S, Greenlee JDW, Howard MA, Mapuskar KA, Seyedin SN, Caster JM, Jones KA, Cullen JJ, Berg DJ, Wagner BA, Buettner GR, TenNapel MJ, Smith BJ, Spitz DR, Buatti JM (2019) First-in-human phase 1 clinical trial of pharmacological ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-19-0594
Altman BJ, Stine ZE, Dang CV (2016) From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer 16(10):619–634. https://doi.org/10.1038/nrc.2016.71
Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR (2009) Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J 418(1):29–37. https://doi.org/10.1042/BJ20081258
Azzam EI, Jay-Gerin JP, Pain D (2012) Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett 327(1–2):48–60. https://doi.org/10.1016/j.canlet.2011.12.012
Banerjee RV, Matthews RG (1990) Cobalamin-dependent methionine synthase. FASEB J 4(5):1450–1459. https://doi.org/10.1096/fasebj.4.5.2407589
Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol Off J Am Soc Clin Oncol 15(5):2040–2049. https://doi.org/10.1200/jco.1997.15.5.2040
Bartrons R, Simon-Molas H, Rodriguez-Garcia A, Castano E, Navarro-Sabate A, Manzano A, Martinez-Outschoorn UE (2018) Fructose 2,6-Bisphosphate in cancer cell metabolism. Front Oncol 8:331. https://doi.org/10.3389/fonc.2018.00331
Baserga R (1992) The double life of the IGF-1 receptor. Receptor 2(4):261–266
Batra V, Kislay B (2013) Mitigation of gamma-radiation induced abasic sites in genomic DNA by dietary nicotinamide supplementation: metabolic up-regulation of NAD(+) biosynthesis. Mutat Res 749(1–2):28–38. https://doi.org/10.1016/j.mrfmmm.2013.07.001
Beck SA, Tisdale MJ (1989) Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res 49(14):3800–3804
Beets GL, Beets-Tan RG (2012) Capecitabine in the treatment of rectal cancer. Lancet Oncol 13(6):560–561. https://doi.org/10.1016/s1470-2045(12)70170-5
Belanger K, Klecker RW Jr, Rowland J, Kinsella TJ, Collins JM (1986) Incorporation of iododeoxyuridine into DNA of granulocytes in patients. Cancer Res 46(12 Pt 1):6509–6512
Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, Thomas CR Jr, Alberts SR, Dawson LA, Micetich KC, Thomas MB, Siegel AB, Blanke CD (2015) SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol Off J Am Soc Clin Oncol 33(24):2617–2622. https://doi.org/10.1200/JCO.2014.60.2219
Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126(1):107–120. https://doi.org/10.1016/j.cell.2006.05.036
Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF, Lafitte JJ, Sculier JP, Project ELCWPftILCS (2008) Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3(1):6–12. https://doi.org/10.1097/JTO.0b013e31815e6d6b
Berrigan D, Perkins SN, Haines DC, Hursting SD (2002) Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23(5):817–822. https://doi.org/10.1093/carcin/23.5.817
Bielski BHJ (1982) Chemistry of ascorbic acid radicals. In: Ascorbic acid: chemistry, metabolism, and uses, vol 200.. Advances in Chemistry, vol 200. American Chemical Society, pp 81–100. https://doi.org/10.1021/ba-1982-0200.ch004
Bischof M, Huber P, Stoffregen C, Wannenmacher M, Weber KJ (2003) Radiosensitization by pemetrexed of human colon carcinoma cells in different cell cycle phases. Int J Radiat Oncol Biol Phys 57(1):289–292. https://doi.org/10.1016/s0360-3016(03)00595-9
Bischof M, Weber KJ, Blatter J, Wannenmacher M, Latz D (2002) Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro. Int J Radiat Oncol Biol Phys 52(5):1381–1388. https://doi.org/10.1016/s0360-3016(01)02794-8
Bogan KL, Brenner C (2008) Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 28:115–130. https://doi.org/10.1146/annurev.nutr.28.061807.155443
Bokkerink JP, De Abreu RA, Bakker MA, Hulscher TW, Van Baal JM, De Vaan GA (1986) Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts. Biochem Pharmacol 35(20):3557–3564. https://doi.org/10.1016/0006-2952(86)90626-x
Bosset J-F, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921. J Clin Oncol 23(24):5620–5627. https://doi.org/10.1200/JCO.2005.02.113
Boysen G, Jamshidi-Parsian A, Davis MA, Siegel ER, Simecka CM, Kore RA, Dings RPM, Griffin RJ (2019) Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice. Int J Radiat Biol 95(4):436–442. https://doi.org/10.1080/09553002.2018.1558299
Brade A, Bezjak A, MacRae R, Laurie S, Sun A, Cho J, Leighl N, Pearson S, Southwood B, Wang L, McGill S, Iscoe N, Shepherd FA (2011) Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 79(5):1395–1401. https://doi.org/10.1016/j.ijrobp.2010.01.014
Brade A, MacRae R, Laurie SA, Bezjak A, Burkes R, Chu Q, Goffin JR, Cho J, Hope A, Sun A, Leighl N, Capobianco S, Feld R, Mahalingam E, Hossain A, Iscoe N, Shepherd FA (2016) Phase II study of concurrent pemetrexed, cisplatin, and radiation therapy for stage IIIA/B unresectable non-small cell lung cancer. Clin Lung Cancer 17(2):133–141. https://doi.org/10.1016/j.cllc.2015.12.008
Breuer W, Shvartsman M, Cabantchik ZI (2008) Intracellular labile iron. Int J Biochem Cell Biol 40(3):350–354. https://doi.org/10.1016/j.biocel.2007.03.010
Brosnan ME, Brosnan JT (2016) Formate: the neglected member of one-carbon metabolism. Annu Rev Nutr 36:369–388. https://doi.org/10.1146/annurev-nutr-071715-050738
Brun E, Kjellén E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, Strand SE (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24(2):127–135
Bruso CE, Shewach DS, Lawrence TS (1990) Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. Int J Radiat Oncol Biol Phys 19(6):1411–1417. https://doi.org/10.1016/0360-3016(90)90352-k
Buettner GR (2011) Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anti Cancer Agents Med Chem 11(4):341–346
Buettner GR, Jurkiewicz BA (1996) Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat Res 145(5):532–541
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625–1638. https://doi.org/10.1056/NEJMoa021423
Calvert AE, Chalastanis A, Wu Y, Hurley LA, Kouri FM, Bi Y, Kachman M, May JL, Bartom E, Hua Y, Mishra RK, Schiltz GE, Dubrovskyi O, Mazar AP, Peter ME, Zheng H, James CD, Burant CF, Chandel NS, Davuluri RV, Horbinski C, Stegh AH (2017) Cancer-associated IDH1 promotes growth and resistance to targeted therapies in the absence of mutation. Cell Rep 19(9):1858–1873. https://doi.org/10.1016/j.celrep.2017.05.014
Cameron E, Campbell A (1974) The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 9(4):285–315. https://doi.org/10.1016/0009-2797(74)90019-2
Cameron E, Campbell A, Jack T (1975) The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact 11(5):387–393. https://doi.org/10.1016/0009-2797(75)90007-1
Cameron E, Pauling L (1976) Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 73(10):3685–3689. https://doi.org/10.1073/pnas.73.10.3685
Cameron E, Pauling L (1978) Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 75(9):4538–4542. https://doi.org/10.1073/pnas.75.9.4538
Campisi J (2013) Aging, cellular senescence, and cancer. Annu Rev Physiol 75:685–705. https://doi.org/10.1146/annurev-physiol-030212-183653
Carreras CW, Santi DV (1995) The catalytic mechanism and structure of thymidylate synthase. Annu Rev Biochem 64:721–762. https://doi.org/10.1146/annurev.bi.64.070195.003445
Cataldi A, Zauli G, Di Pietro R, Castorina S, Rana R (2001) Involvement of the pathway phosphatidylinositol-3-kinase/AKT-1 in the establishment of the survival response to ionizing radiation. Cell Signal 13(5):369–375. https://doi.org/10.1016/s0898-6568(01)00147-4
Cerna D, Li H, Flaherty S, Takebe N, Coleman CN, Yoo SS (2012) Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner. J Biol Chem 287(26):22408–22417. https://doi.org/10.1074/jbc.M112.357301
Chakrabarti G (2015) Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer. Radiat Oncol 10(1):145. https://doi.org/10.1186/s13014-015-0457-x
Champ CE, Baserga R, Mishra MV, Jin L, Sotgia F, Lisanti MP, Pestell RG, Dicker AP, Simone NL (2013) Nutrient restriction and radiation therapy for cancer treatment: when less is more. Oncologist 18(1):97–103. https://doi.org/10.1634/theoncologist.2012-0164
Cheney KE, Liu RK, Smith GS, Meredith PJ, Mickey MR, Walford RL (1983) The effect of dietary restriction of varying duration on survival, tumor patterns, immune function, and body temperature in B10C3F1 female mice. J Gerontol 38(4):420–430. https://doi.org/10.1093/geronj/38.4.420
Chortis V, Taylor AE, Doig CL, Walsh MD, Meimaridou E, Jenkinson C, Rodriguez-Blanco G, Ronchi CL, Jafri A, Metherell LA, Hebenstreit D, Dunn WB, Arlt W, Foster PA (2018) Nicotinamide nucleotide transhydrogenase as a novel treatment target in adrenocortical carcinoma. Endocrinology 159(8):2836–2849. https://doi.org/10.1210/en.2018-00014
Choudhury A, Swindell R, Logue JP, Elliott PA, Livsey JE, Wise M, Symonds P, Wylie JP, Ramani V, Sangar V, Lyons J, Bottomley I, McCaul D, Clarke NW, Kiltie AE, Cowan RA (2011) Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer. J Clin Oncol Off J Am Soc Clin Oncol 29(6):733–738. https://doi.org/10.1200/jco.2010.31.5721
Cohen CW, Fontaine KR, Arend RC, Soleymani T, Gower BA (2018) Favorable effects of a ketogenic diet on physical function, perceived energy, and food cravings in women with ovarian or endometrial cancer: a randomized, controlled trial. Nutrients 10(9). https://doi.org/10.3390/nu10091187
Cohen MH, Cortazar P, Justice R, Pazdur R (2010) Approval summary: pemetrexed maintenance therapy of advanced/metastatic nonsquamous, non-small cell lung cancer (NSCLC). Oncologist 15(12):1352–1358. https://doi.org/10.1634/theoncologist.2010-0224
Collins RRJ, Patel K, Putnam WC, Kapur P, Rakheja D (2017) Oncometabolites: a new paradigm for oncology, metabolism, and the clinical laboratory. Clin Chem 63(12):1812–1820. https://doi.org/10.1373/clinchem.2016.267666
Condit PT, Ridings GR, Coin JW, Williams GR, Mitchell D Jr, Boles GW (1964) Methotrexate and radiation in the treatment of patients with cancer. Cancer Res 24:1524–1533
Conklin KA (2004) Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 3(4):294–300. https://doi.org/10.1177/1534735404270335
Cosaceanu D, Budiu RA, Carapancea M, Castro J, Lewensohn R, Dricu A (2007) Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism. Oncogene 26(17):2423–2434. https://doi.org/10.1038/sj.onc.1210037
Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S (1979) Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 301(13):687–690. https://doi.org/10.1056/NEJM197909273011303
Cuneo KC, Morgan MA, Sahai V, Schipper MJ, Parsels LA, Parsels JD, Devasia T, Al-Hawaray M, Cho CS, Nathan H, Maybaum J, Zalupski MM, Lawrence TS (2019) Dose escalation trial of the Wee1 inhibitor Adavosertib (AZD1775) in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer. J Clin Oncol:Jco1900730. https://doi.org/10.1200/jco.19.00730
De Vos M, Schreiber V, Dantzer F (2012) The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem Pharmacol 84(2):137–146. https://doi.org/10.1016/j.bcp.2012.03.018
DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2(5):e1600200. https://doi.org/10.1126/sciadv.1600200
Demas DM, Demo S, Fallah Y, Clarke R, Nephew KP, Althouse S, Sandusky G, He W, Shajahan-Haq AN (2019) Glutamine metabolism drives growth in advanced hormone receptor positive breast cancer. Front Oncol 9:686. https://doi.org/10.3389/fonc.2019.00686
DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, Scrimieri F, Winter JM, Hruban RH, Iacobuzio-Donahue C, Kern SE, Blair IA, Tuveson DA (2011) Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475(7354):106–109. https://doi.org/10.1038/nature10189
Dev S, Babitt JL (2017) Overview of iron metabolism in health and disease. Hemodial Int 21(Suppl 1):S6–S20. https://doi.org/10.1111/hdi.12542
Dias MC, Ribeiro AG, Scabim VM, Faintuch J, Zilberstein B, Gama-Rodrigues JJ (2006) Dietary intake of female bariatric patients after anti-obesity gastroplasty. Clinics (Sao Paulo) 61(2):93–98. https://doi.org/10.1590/s1807-59322006000200002
Dibble CC, Manning BD (2013) Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol 15(6):555–564. https://doi.org/10.1038/ncb2763
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780–783. https://doi.org/10.1038/nature07733
Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66(6):1191–1308
Du J, Cullen JJ, Buettner GR (2012) Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta 1826(2):443–457. https://doi.org/10.1016/j.bbcan.2012.06.003
Ducker GS, Ghergurovich JM, Mainolfi N, Suri V, Jeong SK, Hsin-Jung Li S, Friedman A, Manfredi MG, Gitai Z, Kim H, Rabinowitz JD (2017) Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. Proc Natl Acad Sci 114(43):11404–11409. https://doi.org/10.1073/pnas.1706617114
Ducker GS, Rabinowitz JD (2017) One-carbon metabolism in health and disease. Cell Metab 25(1):27–42. https://doi.org/10.1016/j.cmet.2016.08.009
Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, Barrett JC (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57(21):4667–4672
El Mjiyad N, Caro-Maldonado A, Ramirez-Peinado S, Munoz-Pinedo C (2011) Sugar-free approaches to cancer cell killing. Oncogene 30(3):253–264. https://doi.org/10.1038/onc.2010.466
Elledge SJ, Davis RW (1989) DNA damage induction of ribonucleotide reductase. Mol Cell Biol 9(11):4932–4940. https://doi.org/10.1128/mcb.9.11.4932
Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD (2014) Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510(7504):298–302. https://doi.org/10.1038/nature13236
Farber S, Diamond LK (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 238(23):787–793. https://doi.org/10.1056/nejm194806032382301
Fehlauer F, Muench M, Smid EJ, Slotman B, Richter E, Van der Valk P, Sminia P (2006) Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue. Oncol Rep 15(1):97–105
Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, Tallman MS, Sun Z, Wolniak K, Peeters JK, Liu W, Choe SE, Fantin VR, Paietta E, Lowenberg B, Licht JD, Godley LA, Delwel R, Valk PJ, Thompson CB, Levine RL, Melnick A (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18(6):553–567. https://doi.org/10.1016/j.ccr.2010.11.015
Fischer M (2017) Census and evaluation of p53 target genes. Oncogene 36(28):3943–3956. https://doi.org/10.1038/onc.2016.502
Flanagan SA, Cooper KS, Mannava S, Nikiforov MA, Shewach DS (2012) Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization. Int J Radiat Oncol Biol Phys 84(5):e613–e620. https://doi.org/10.1016/j.ijrobp.2012.06.050
Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287(5460):2017–2019. https://doi.org/10.1126/science.287.5460.2017
Floberg JM, Schwarz JK (2019) Manipulation of glucose and hydroperoxide metabolism to improve radiation response. Semin Radiat Oncol 29(1):33–41. https://doi.org/10.1016/j.semradonc.2018.10.007
Fontana L, Partridge L, Longo VD (2010) Extending healthy life span—from yeast to humans. Science 328(5976):321–326. https://doi.org/10.1126/science.1172539
Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ, Cohen P, Hwang D, Peterson B, Fields T, Pizzo SV, Isaacs WB (2008) Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68(1):11–19. https://doi.org/10.1002/pros.20683
Frei B, Lawson S (2008) Vitamin C and cancer revisited. Proc Natl Acad Sci U S A 105(32):11037–11038. https://doi.org/10.1073/pnas.0806433105
Galan-Cobo A, Sitthideatphaiboon P, Qu X, Poteete A, Pisegna MA, Tong P, Chen PH, Boroughs LK, Rodriguez MLM, Zhang W, Parlati F, Wang J, Gandhi V, Skoulidis F, DeBerardinis RJ, Minna JD, Heymach JV (2019) LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma. Cancer Res 79(13):3251–3267. https://doi.org/10.1158/0008-5472.CAN-18-3527
Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2(9):683–693. https://doi.org/10.1038/nrc882
Gao X, Sanderson SM, Dai Z, Reid MA, Cooper DE, Lu M, Richie JP Jr, Ciccarella A, Calcagnotto A, Mikhael PG, Mentch SJ, Liu J, Ables G, Kirsch DG, Hsu DS, Nichenametla SN, Locasale JW (2019) Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature 572(7769):397–401. https://doi.org/10.1038/s41586-019-1437-3
Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891–899. https://doi.org/10.1038/nrc1478
Gatenby RA, Vincent TL (2003) An evolutionary model of carcinogenesis. Cancer Res 63(19):6212–6220
George TJ, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, Wolmark N (2019) NRG-GI002: a phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—first experimental arm (EA) initial results. J Clin Oncol 37(15_suppl):3505–3505. https://doi.org/10.1200/JCO.2019.37.15_suppl.3505
Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol Off J Am Soc Clin Oncol 24(28):4620–4625. https://doi.org/10.1200/jco.2006.06.7629
Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379(6560):88–91. https://doi.org/10.1038/379088a0
Graumlich JF, Ludden TM, Conry-Cantilena C, Cantilena LR Jr, Wang Y, Levine M (1997) Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharm Res 14(9):1133–1139. https://doi.org/10.1023/a:1012186203165
Gregory MA, Nemkov T, Park HJ, Zaberezhnyy V, Gehrke S, Adane B, Jordan CT, Hansen KC, D'Alessandro A, DeGregori J (2019) Targeting glutamine metabolism and redox state for Leukemia therapy. Clin Cancer Res 25(13):4079–4090. https://doi.org/10.1158/1078-0432.CCR-18-3223
Grem JL (2000) 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Investig New Drugs 18(4):299–313. https://doi.org/10.1023/a:1006416410198
Grommes C, DeAngelis LM (2017) Primary CNS lymphoma. J Clin Oncol 35(21):2410–2418. https://doi.org/10.1200/JCO.2017.72.7602
Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J, Mackinnon AL, Parlati F, Rodriguez ML, Shwonek PJ, Sjogren EB, Stanton TF, Wang T, Yang J, Zhao F, Bennett MK (2014) Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther 13(4):890–901. https://doi.org/10.1158/1535-7163.MCT-13-0870
Gujar AD, Le S, Mao DD, Dadey DYA, Turski A, Sasaki Y, Aum D, Luo J, Dahiya S, Yuan L, Rich KM, Milbrandt J, Hallahan DE, Yano H, Tran DD, Kim AH (2016) An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc Natl Acad Sci 113(51):E8247–E8256. https://doi.org/10.1073/pnas.1610921114
Gunda V, Souchek J, Abrego J, Shukla SK, Goode GD, Vernucci E, Dasgupta A, Chaika NV, King RJ, Li S, Wang S, Yu F, Bessho T, Lin C, Singh PK (2017) MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clin Cancer Res 23(19):5881–5891. https://doi.org/10.1158/1078-0432.CCR-17-1151
Gupta AK, Cerniglia GJ, Mick R, Ahmed MS, Bakanauskas VJ, Muschel RJ, McKenna WG (2003) Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002. Int J Radiat Oncol Biol Phys 56(3):846–853. https://doi.org/10.1016/s0360-3016(03)00214-1
Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, Gaulard P, Garderet L, Lepage E, Reyes F, Meignan M (2005) [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 106(4):1376–1381. https://doi.org/10.1182/blood-2005-01-0272
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013
Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA, Elia A, Berger T, Cescon DW, Adeoye A, Brustle A, Molyneux SD, Mason JM, Li WY, Yamamoto K, Wakeham A, Berman HK, Khokha R, Done SJ, Kavanagh TJ, Lam CW, Mak TW (2015) Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27(2):211–222. https://doi.org/10.1016/j.ccell.2014.11.019
Heilbronn LK, de Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, Nguyen T, Martin CK, Volaufova J, Most MM, Greenway FL, Smith SR, Deutsch WA, Williamson DA, Ravussin E, Pennington CT (2006) Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295(13):1539–1548. https://doi.org/10.1001/jama.295.13.1539
Heinemann V, Hertel LW, Grindey GB, Plunkett W (1988) Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Cancer Res 48(14):4024–4031
Hitchins RN, Bell DR, Woods RL, Levi JA (1987) A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5(10):1655–1662. https://doi.org/10.1200/JCO.1987.5.10.1655
Hite AH, Berkowitz VG, Berkowitz K (2011) Low-carbohydrate diet review: shifting the paradigm. Nutr Clin Pract 26(3):300–308. https://doi.org/10.1177/0884533611405791
Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L, Miller WH Jr (2008) Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol 19(11):1969–1974. https://doi.org/10.1093/annonc/mdn377
Hofheinz RD, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT, Muller L, Link H, Moehler M, Kettner E, Fritz E, Hieber U, Lindemann HW, Grunewald M, Kremers S, Constantin C, Hipp M, Hartung G, Gencer D, Kienle P, Burkholder I, Hochhaus A (2012) Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 13(6):579–588. https://doi.org/10.1016/s1470-2045(12)70116-x
Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W (1991) Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 51(22):6110–6117
Hursting SD, Kari FW (1999) The anti-carcinogenic effects of dietary restriction: mechanisms and future directions. Mutat Res 443(1–2):235–249. https://doi.org/10.1016/s1383-5742(99)00021-6
Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC (2003) Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54:131–152. https://doi.org/10.1146/annurev.med.54.101601.152156
Hursting SD, Switzer BR, French JE, Kari FW (1993) The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res 53(12):2750–2757
Ilic N, Birsoy K, Aguirre AJ, Kory N, Pacold ME, Singh S, Moody SE, DeAngelo JD, Spardy NA, Freinkman E, Weir BA, Tsherniak A, Cowley GS, Root DE, Asara JM, Vazquez F, Widlund HR, Sabatini DM, Hahn WC (2017) PIK3CA mutant tumors depend on oxoglutarate dehydrogenase. Proc Natl Acad Sci U S A 114(17):E3434–E3443. https://doi.org/10.1073/pnas.1617922114
Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320(5876):661–664. https://doi.org/10.1126/science.1156906
Itsumi M, Inoue S, Elia AJ, Murakami K, Sasaki M, Lind EF, Brenner D, Harris IS, Chio II, Afzal S, Cairns RA, Cescon DW, Elford AR, Ye J, Lang PA, Li WY, Wakeham A, Duncan GS, Haight J, You-Ten A, Snow B, Yamamoto K, Ohashi PS, Mak TW (2015) Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio. Cell Death Differ 22(11):1837–1845. https://doi.org/10.1038/cdd.2015.38
Jacque N, Ronchetti AM, Larrue C, Meunier G, Birsen R, Willems L, Saland E, Decroocq J, Maciel TT, Lambert M, Poulain L, Hospital MA, Sujobert P, Joseph L, Chapuis N, Lacombe C, Moura IC, Demo S, Sarry JE, Recher C, Mayeux P, Tamburini J, Bouscary D (2015) Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood 126(11):1346–1356. https://doi.org/10.1182/blood-2015-01-621870
Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho A, Feng FY, Speers C, Overmoyer B, Sabel M, Schott AF, Pierce L (2018) Concurrent veliparib with chest wall and nodal radiotherapy in patients with inflammatory or locoregionally recurrent breast cancer: the TBCRC 024 phase I multicenter study. J Clin Oncol Off J Am Soc Clin Oncol 36(13):1317–1322. https://doi.org/10.1200/jco.2017.77.2665
Jakob CG, Upadhyay AK, Donner PL, Nicholl E, Addo SN, Qiu W, Ling C, Gopalakrishnan SM, Torrent M, Cepa SP, Shanley J, Shoemaker AR, Sun CC, Vasudevan A, Woller KR, Shotwell JB, Shaw B, Bian Z, Hutti JE (2018) Novel modes of inhibition of wild-type Isocitrate dehydrogenase 1 (IDH1): direct covalent modification of His315. J Med Chem 61(15):6647–6657. https://doi.org/10.1021/acs.jmedchem.8b00305
Kanarek N, Keys HR, Cantor JR, Lewis CA, Chan SH, Kunchok T, Abu-Remaileh M, Freinkman E, Schweitzer LD, Sabatini DM (2018) Histidine catabolism is a major determinant of methotrexate sensitivity. Nature 559(7715):632–636. https://doi.org/10.1038/s41586-018-0316-7
Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N (2002) Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22(22):7831–7841. https://doi.org/10.1128/mcb.22.22.7831-7841.2002
Kaplan J, Ward DM (2013) The essential nature of iron usage and regulation. Curr Biol 23(15):R642–R646. https://doi.org/10.1016/j.cub.2013.05.033
Kato H, Ito E, Shi W, Alajez NM, Yue S, Lee C, Chan N, Bhogal N, Coackley CL, Vines D, Green D, Waldron J, Gullane P, Bristow R, Liu FF (2010) Efficacy of combining GMX1777 with radiation therapy for human head and neck carcinoma. Clin Cancer Res 16(3):898–911. https://doi.org/10.1158/1078-0432.ccr-09-1945
Kauppi B, Nielsen BB, Ramaswamy S, Kjøller Larsen I, Thelander M, Thelander L, Eklund H (1996) The three-dimensional structure of mammalian ribonucleotide reductase protein R2 reveals a more-accessible iron-radical site than Escherichia coli R2. J Mol Biol 262(5):706–720. https://doi.org/10.1006/jmbi.1996.0546
Kawamura K, Qi F, Kobayashi J (2018) Potential relationship between the biological effects of low-dose irradiation and mitochondrial ROS production. J Radiat Res 59(suppl_2):ii91–ii97. https://doi.org/10.1093/jrr/rrx091
Kennedy CR, Tilkens SB, Guan H, Garner JA, Or PM, Chan AM (2013) Differential sensitivities of glioblastoma cell lines towards metabolic and signaling pathway inhibitions. Cancer Lett 336(2):299–306. https://doi.org/10.1016/j.canlet.2013.03.020
Kesarwani P, Prabhu A, Kant S, Kumar P, Graham SF, Buelow KL, Wilson GD, Miller CR, Chinnaiyan P (2018) Tryptophan metabolism contributes to radiation-induced immune checkpoint reactivation in glioblastoma. Clin Cancer Res 24(15):3632–3643. https://doi.org/10.1158/1078-0432.ccr-18-0041
Kidd EA, Siegel BA, Dehdashti F, Grigsby PW (2007) The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 110(8):1738–1744. https://doi.org/10.1002/cncr.22974
Kim A, Lee JE, Jang WS, Lee SJ, Park S, Kang HJ, Lee SS (2012) A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-kappaB signaling. Leuk Res 36(3):350–357. https://doi.org/10.1016/j.leukres.2011.07.027
Kim D, Fiske BP, Birsoy K, Freinkman E, Kami K, Possemato RL, Chudnovsky Y, Pacold ME, Chen WW, Cantor JR, Shelton LM, Gui DY, Kwon M, Ramkissoon SH, Ligon KL, Kang SW, Snuderl M, Vander Heiden MG, Sabatini DM (2015) SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature 520(7547):363–367. https://doi.org/10.1038/nature14363
Kim MM, Camelo-Piragua S, Schipper M, Tao Y, Normolle D, Junck L, Mammoser A, Betz BL, Cao Y, Kim CJ, Heth J, Sagher O, Lawrence TS, Tsien CI (2016) Gemcitabine plus radiation therapy for high-grade glioma: long-term results of a phase 1 dose-escalation study. Int J Radiat Oncol Biol Phys 94(2):305–311. https://doi.org/10.1016/j.ijrobp.2015.10.032
Kinsella TJ, Collins J, Rowland J, Klecker R Jr, Wright D, Katz D, Steinberg SM, Glastein E (1988) Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol Off J Am Soc Clin Oncol 6(5):871–879. https://doi.org/10.1200/jco.1988.6.5.871
Kinsella TJ, Kunugi KA, Vielhuber KA, Potter DM, Fitzsimmons ME, Collins JM (1998) Preclinical evaluation of 5-iodo-2-pyrimidinone-2′-deoxyribose as a prodrug for 5-iodo-2′-deoxyuridine-mediated radiosensitization in mouse and human tissues. Clin Cancer Res 4(1):99–109
Ko YH, Domingo-Vidal M, Roche M, Lin Z, Whitaker-Menezes D, Seifert E, Capparelli C, Tuluc M, Birbe RC, Tassone P, Curry JM, Navarro-Sabate A, Manzano A, Bartrons R, Caro J, Martinez-Outschoorn U (2016) TP53-inducible glycolysis and apoptosis regulator (TIGAR) metabolically reprograms carcinoma and stromal cells in breast cancer. J Biol Chem 291(51):26291–26303. https://doi.org/10.1074/jbc.M116.740209
Koriech OM (1994) Diet and cancer. J Family Community Med 1(1):2–11
Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 13(6):472–482. https://doi.org/10.1016/j.ccr.2008.05.005
Kruiswijk F, Labuschagne CF, Vousden KH (2015) p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol 16(7):393–405. https://doi.org/10.1038/nrm4007
Kruszewski M (2003) Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res 531(1–2):81–92. https://doi.org/10.1016/j.mrfmmm.2003.08.004
Kummar S, Anderson L, Hill K, Majerova E, Allen D, Horneffer Y, Ivy SP, Rubinstein L, Harris P, Doroshow JH, Collins JM (2013) First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2′-deoxyribose in patients with advanced malignancies. Clin Cancer Res 19(7):1852–1857. https://doi.org/10.1158/1078-0432.ccr-12-3118
Kunos CA, Radivoyevitch T, Pink J, Chiu SM, Stefan T, Jacobberger J, Kinsella TJ (2010) Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers. Radiat Res 174(5):574–581. https://doi.org/10.1667/RR2273.1
Lane AN, Fan TWM (2015) Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res 43(4):2466–2485. https://doi.org/10.1093/nar/gkv047
Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewach DS (1996) Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys 34(4):867–872. https://doi.org/10.1016/0360-3016(95)02134-5
Lawrence TS, Davis MA, Maybaum J, Stetson PL, Ensminger WD (1990) The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure. Int J Radiat Oncol Biol Phys 18(6):1393–1398. https://doi.org/10.1016/0360-3016(90)90313-9
Lawrence TS, Eisbruch A, McGinn CJ, Fields MT, Shewach DS (1999) Radiosensitization by gemcitabine. Oncology (Williston Park) 13(10 Suppl 5):55–60
Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, Hwang D, Cohen P, Bianchi G, Longo VD (2010) Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res 70(4):1564–1572. https://doi.org/10.1158/0008-5472.CAN-09-3228
Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS (2005) Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 63(4):1037–1044. https://doi.org/10.1016/j.ijrobp.2005.04.034
Lee EW, Lee MS, Camus S, Ghim J, Yang MR, Oh W, Ha NC, Lane DP, Song J (2009) Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J 28(14):2100–2113. https://doi.org/10.1038/emboj.2009.164
Lee JH, Kim SY, Kil IS, Park JW (2007) Regulation of ionizing radiation-induced apoptosis by mitochondrial NADP+-dependent isocitrate dehydrogenase. J Biol Chem 282(18):13385–13394. https://doi.org/10.1074/jbc.M700303200
Lee SH, Jo SH, Lee SM, Koh HJ, Song H, Park JW, Lee WH, Huh TL (2004) Role of NADP+-dependent isocitrate dehydrogenase (NADP+-ICDH) on cellular defence against oxidative injury by gamma-rays. Int J Radiat Biol 80(9):635–642. https://doi.org/10.1080/09553000400007680
Lesueur P, Lequesne J, Grellard J-M, Dugué A, Coquan E, Brachet P-E, Geffrelot J, Kao W, Emery E, Berro DH, Castera L, Goardon N, Lacroix J, Lange M, Capel A, Leconte A, Andre B, Léger A, Lelaidier A, Clarisse B, Stefan D (2019) Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol. BMC Cancer 19(1):198. https://doi.org/10.1186/s12885-019-5413-y
Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 93(8):3704–3709. https://doi.org/10.1073/pnas.93.8.3704
Lewis JE, Singh N, Holmila RJ, Sumer BD, Williams NS, Furdui CM, Kemp ML, Boothman DA (2019) Targeting NAD(+) metabolism to enhance radiation therapy responses. Semin Radiat Oncol 29(1):6–15. https://doi.org/10.1016/j.semradonc.2018.10.009
Li K, Reichmann H (2016) Role of iron in neurodegenerative diseases. J Neural Transm (Vienna) 123(4):389–399. https://doi.org/10.1007/s00702-016-1508-7
Li L, Fath MA, Scarbrough PM, Watson WH, Spitz DR (2015) Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer. Redox Biol 4:127–135. https://doi.org/10.1016/j.redox.2014.12.001
Li S, Zhuang Z, Wu T, Lin J-C, Liu Z-X, Zhou L-F, Dai T, Lu L, Ju H-Q (2018) Nicotinamide nucleotide transhydrogenase-mediated redox homeostasis promotes tumor growth and metastasis in gastric cancer. Redox Biol 18:246–255. https://doi.org/10.1016/j.redox.2018.07.017
Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W (2012) Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149(6):1269–1283. https://doi.org/10.1016/j.cell.2012.04.026
Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, Wong LC, Ngan HY (2001) High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61(16):5998–6001
Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H, Colvin R, Ding J, Tong L, Wu S, Hines J, Chen X (2012) A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther 11(8):1672–1682. https://doi.org/10.1158/1535-7163.MCT-12-0131
Locasale JW (2013) Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13(8):572–583. https://doi.org/10.1038/nrc3557
Loehrer PJ, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, Flynn P, Ramanathan RK, Crane CH, Alberts SR, Benson AB (2011) Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial. J Clin Oncol 29(31):4105–4112. https://doi.org/10.1200/JCO.2011.34.8904
Love NR, Pollak N, Dölle C, Niere M, Chen Y, Oliveri P, Amaya E, Patel S, Ziegler M (2015) NAD kinase controls animal NADP biosynthesis and is modulated via evolutionarily divergent calmodulin-dependent mechanisms. Proc Natl Acad Sci 112(5):1386–1391. https://doi.org/10.1073/pnas.1417290112
Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, Wellen KE, O'Rourke DM, Berger SL, Chan TA, Levine RL, Mellinghoff IK, Thompson CB (2012) IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483(7390):474–478. https://doi.org/10.1038/nature10860
Luengo A, Gui DY, Vander Heiden MG (2017) Targeting metabolism for cancer therapy. Cell Chem Biol 24(9):1161–1180. https://doi.org/10.1016/j.chembiol.2017.08.028
Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q (2014) High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med 6(222):222ra218. https://doi.org/10.1126/scitranslmed.3007154
Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725–730. https://doi.org/10.1056/NEJMoa010187
Maddocks ODK, Athineos D, Cheung EC, Lee P, Zhang T, van den Broek NJF, Mackay GM, Labuschagne CF, Gay D, Kruiswijk F, Blagih J, Vincent DF, Campbell KJ, Ceteci F, Sansom OJ, Blyth K, Vousden KH (2017) Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 544:372. https://doi.org/10.1038/nature22056. https://www.nature.com/articles/nature22056#supplementary-information
Maddocks ODK, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, Vousden KH (2012) Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493:542. https://doi.org/10.1038/nature11743. https://www.nature.com/articles/nature11743#supplementary-information
Matre P, Velez J, Jacamo R, Qi Y, Su X, Cai T, Chan SM, Lodi A, Sweeney SR, Ma H, Davis RE, Baran N, Haferlach T, Su X, Flores ER, Gonzalez D, Konoplev S, Samudio I, DiNardo C, Majeti R, Schimmer AD, Li W, Wang T, Tiziani S, Konopleva M (2016) Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes. Oncotarget 7(48):79722–79735. https://doi.org/10.18632/oncotarget.12944
Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science (New York, NY) 316(5828):1160–1166. https://doi.org/10.1126/science.1140321
Maurer GD, Brucker DP, Bahr O, Harter PN, Hattingen E, Walenta S, Mueller-Klieser W, Steinbach JP, Rieger J (2011) Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer 11:315. https://doi.org/10.1186/1471-2407-11-315
Mavropoulos JC, Buschemeyer WC 3rd, Tewari AK, Rokhfeld D, Pollak M, Zhao Y, Febbo PG, Cohen P, Hwang D, Devi G, Demark-Wahnefried W, Westman EC, Peterson BL, Pizzo SV, Freedland SJ (2009) The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prev Res (Phila) 2(6):557–565. https://doi.org/10.1158/1940-6207.CAPR-08-0188
May JL, Kouri FM, Hurley LA, Liu J, Tommasini-Ghelfi S, Ji Y, Gao P, Calvert AE, Lee A, Chandel NS, Davuluri RV, Horbinski CM, Locasale JW, Stegh AH (2019) IDH3alpha regulates one-carbon metabolism in glioblastoma. Sci Adv 5(1):eaat0456. https://doi.org/10.1126/sciadv.aat0456
McBrayer SK, Cheng JC, Singhal S, Krett NL, Rosen ST, Shanmugam M (2012) Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy. Blood 119(20):4686–4697. https://doi.org/10.1182/blood-2011-09-377846
McBrayer SK, Mayers JR, DiNatale GJ, Shi DD, Khanal J, Chakraborty AA, Sarosiek KA, Briggs KJ, Robbins AK, Sewastianik T, Shareef SJ, Olenchock BA, Parker SJ, Tateishi K, Spinelli JB, Islam M, Haigis MC, Looper RE, Ligon KL, Bernstein BE, Carrasco RD, Cahill DP, Asara JM, Metallo CM, Yennawar NH, Vander Heiden MG, Kaelin WG Jr (2018) Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma. Cell 175(1):101–116. e125. https://doi.org/10.1016/j.cell.2018.08.038
Mehrmohamadi M, Liu X, Shestov AA, Locasale JW (2014) Characterization of the usage of the serine metabolic network in human cancer. Cell Rep 9(4):1507–1519. https://doi.org/10.1016/j.celrep.2014.10.026
Mellemkjaer L, Emborg C, Gridley G, Munk-Jorgensen P, Johansen C, Tjonneland A, Kjaer SK, Olsen JH (2001) Anorexia nervosa and cancer risk. Cancer Causes Control 12(2):173–177
Meulendijks D, Dewit L, Tomasoa NB, van Tinteren H, Beijnen JH, Schellens JHM, Cats A (2014) Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. Br J Cancer 111(9):1726–1733. https://doi.org/10.1038/bjc.2014.467
Michels KB, Ekbom A (2004) Caloric restriction and incidence of breast cancer. JAMA 291(10):1226–1230. https://doi.org/10.1001/jama.291.10.1226
Miller DM, Buettner GR, Aust SD (1990) Transition metals as catalysts of "autoxidation" reactions. Free Radic Biol Med 8(1):95–108. https://doi.org/10.1016/0891-5849(90)90148-c
Moertel C, Reitemeier R, Childs D, Colby M, Holbrook M (1969) Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 294(7626):865–867. https://doi.org/10.1016/S0140-6736(69)92326-5
Mohanti BK, Rath GK, Anantha N, Kannan V, Das BS, Chandramouli BA, Banerjee AK, Das S, Jena A, Ravichandran R, Sahi UP, Kumar R, Kapoor N, Kalia VK, Dwarakanath BS, Jain V (1996) Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys 35(1):103–111
Momcilovic M, Bailey ST, Lee JT, Fishbein MC, Magyar C, Braas D, Graeber T, Jackson NJ, Czernin J, Emberley E, Gross M, Janes J, Mackinnon A, Pan A, Rodriguez M, Works M, Zhang W, Parlati F, Demo S, Garon E, Krysan K, Walser TC, Dubinett SM, Sadeghi S, Christofk HR, Shackelford DB (2017) Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer. Cell Rep 18(3):601–610. https://doi.org/10.1016/j.celrep.2016.12.061
Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, Pillai MV, Newberg AB, Deshmukh S, Levine M (2012) Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One 7(1):e29794. https://doi.org/10.1371/journal.pone.0029794
Moser JC, Rawal M, Wagner BA, Du J, Cullen JJ, Buettner GR (2013) Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer. Redox Biol 2:22–27. https://doi.org/10.1016/j.redox.2013.11.005
Mullarky E, Mattaini KR, Vander Heiden MG, Cantley LC, Locasale JW (2011) PHGDH amplification and altered glucose metabolism in human melanoma. Pigment Cell Melanoma Res 24(6):1112–1115. https://doi.org/10.1111/j.1755-148X.2011.00919.x
Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH (2008) The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 7(6):500–506. https://doi.org/10.1016/S1474-4422(08)70092-9
Nebeling LC, Miraldi F, Shurin SB, Lerner E (1995) Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr 14(2):202–208. https://doi.org/10.1080/07315724.1995.10718495
Niida H, Katsuno Y, Sengoku M, Shimada M, Yukawa M, Ikura M, Ikura T, Kohno K, Shima H, Suzuki H, Tashiro S, Nakanishi M (2010) Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase. Genes Dev 24(4):333–338. https://doi.org/10.1101/gad.1863810
Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, Kampf C, Huang J, Asplund A, Mootha VK (2014) Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun 5(1):3128. https://doi.org/10.1038/ncomms4128
Nishikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E, Inoue M (2001) Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61(5):1843–1845
Nordlund P, Reichard P (2006) Ribonucleotide reductases. Annu Rev Biochem 75(1):681–706. https://doi.org/10.1146/annurev.biochem.75.103004.142443
Otto C, Kaemmerer U, Illert B, Muehling B, Pfetzer N, Wittig R, Voelker HU, Thiede A, Coy JF (2008) Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer 8:122. https://doi.org/10.1186/1471-2407-8-122
Pacold ME, Brimacombe KR, Chan SH, Rohde JM, Lewis CA, Swier LJ, Possemato R, Chen WW, Sullivan LB, Fiske BP, Cho S, Freinkman E, Birsoy K, Abu-Remaileh M, Shaul YD, Liu CM, Zhou M, Koh MJ, Chung H, Davidson SM, Luengo A, Wang AQ, Xu X, Yasgar A, Liu L, Rai G, Westover KD, Vander Heiden MG, Shen M, Gray NS, Boxer MB, Sabatini DM (2016) A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol 12(6):452–458. https://doi.org/10.1038/nchembio.2070
Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M (2004) Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 140(7):533–537. https://doi.org/10.7326/0003-4819-140-7-200404060-00010
Pai YJ, Leung KY, Savery D, Hutchin T, Prunty H, Heales S, Brosnan ME, Brosnan JT, Copp AJ, Greene ND (2015) Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. Nat Commun 6:6388. https://doi.org/10.1038/ncomms7388
Pan Z, Yang G, He H, Zhao G, Yuan T, Li Y, Shi W, Gao P, Dong L, Li Y (2016) Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: a prospective and single-arm study. Int J Cancer 139(8):1864–1872. https://doi.org/10.1002/ijc.30214
Parr T (1996) Insulin exposure controls the rate of mammalian aging. Mech Ageing Dev 88(1–2):75–82. https://doi.org/10.1016/0047-6374(96)01723-x
Pauwels B, Korst AEC, Lardon F, Vermorken JB (2005) Combined modality therapy of gemcitabine and radiation. Oncologist 10(1):34–51. https://doi.org/10.1634/theoncologist.10-1-34
Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27–47. https://doi.org/10.1016/j.cmet.2015.12.006
Pelicano H, Martin DS, Xu RH, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25(34):4633–4646. https://doi.org/10.1038/sj.onc.1209597
Petronek MS, Spitz DR, Buettner GR, Allen BG (2019) Linking cancer metabolic dysfunction and genetic instability through the lens of iron metabolism. Cancers (Basel) 11(8). https://doi.org/10.3390/cancers11081077
Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 102(3):719–724. https://doi.org/10.1073/pnas.0408894102
Peylan-Ramu N, Poplack DG, Pizzo PA, Adornato BT, Di Chiro G (1978) Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 298(15):815–818. https://doi.org/10.1056/nejm197804132981504
Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR (2000) Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 275(52):40974–40980. https://doi.org/10.1074/jbc.M006520200
Pollak N, Dolle C, Ziegler M (2007) The power to reduce: pyridine nucleotides--small molecules with a multitude of functions. Biochem J 402(2):205–218. https://doi.org/10.1042/BJ20061638
Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW, Vogelstein B (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20(3):291–293. https://doi.org/10.1038/3108
Pongratz RL, Kibbey RG, Shulman GI, Cline GW (2007) Cytosolic and mitochondrial malic enzyme isoforms differentially control insulin secretion. J Biol Chem 282(1):200–207. https://doi.org/10.1074/jbc.M602954200
Popovtzer A, Normolle D, Worden FP, Prince ME, Chepeha DB, Wolf GT, Bradford CR, Lawrence TS, Eisbruch A (2014) Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio. Transl Oncol 7(4):479–483. https://doi.org/10.1016/j.tranon.2014.04.016
Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo H-K, Jang HG, Jha AK, Chen WW, Barrett FG, Stransky N, Tsun Z-Y, Cowley GS, Barretina J, Kalaany NY, Hsu PP, Ottina K, Chan AM, Yuan B, Garraway LA, Root DE, Mino-Kenudson M, Brachtel EF, Driggers EM, Sabatini DM (2011) Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476(7360):346–350. https://doi.org/10.1038/nature10350
Price BD, Youmell MB (1996) The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res 56(2):246–250
Price GS, Page RL, Riviere JE, Cline JM, Thrall DE (1996) Pharmacokinetics and toxicity of oral and intravenous lonidamine in dogs. Cancer Chemother Pharmacol 38(2):129–135
Qian SY, Buettner GR (1999) Iron and dioxygen chemistry is an important route to initiation of biological free radical oxidations: an electron paramagnetic resonance spin trapping study. Free Radic Biol Med 26(11–12):1447–1456. https://doi.org/10.1016/s0891-5849(99)00002-7
Qie S, Yoshida A, Parnham S, Oleinik N, Beeson GC, Beeson CC, Ogretmen B, Bass AJ, Wong KK, Rustgi AK, Diehl JA (2019) Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nat Commun 10(1):1296. https://doi.org/10.1038/s41467-019-09179-w
Quinlan CL, Kaiser SE, Bolaños B, Nowlin D, Grantner R, Karlicek-Bryant S, Feng JL, Jenkinson S, Freeman-Cook K, Dann SG, Wang X, Wells PA, Fantin VR, Stewart AE, Grant SK (2017) Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A. Nat Chem Biol 13:785. https://doi.org/10.1038/nchembio.2384. https://www.nature.com/articles/nchembio.2384#supplementary-information
Lippincott Williams & Wilkins (2012) Radiobiology for the radiologist, 7th edn. Lippincott Williams & Wilkins. Wolters Kluwer, Philadelphia, PA
Rashmi R, Huang X, Floberg JM, Elhammali AE, McCormick ML, Patti GJ, Spitz DR, Schwarz JK (2018) Radioresistant cervical cancers are sensitive to inhibition of glycolysis and redox metabolism. Cancer Res 78(6):1392–1403. https://doi.org/10.1158/0008-5472.CAN-17-2367
Reckzeh ES, Karageorgis G, Schwalfenberg M, Ceballos J, Nowacki J, Stroet MCM, Binici A, Knauer L, Brand S, Choidas A, Strohmann C, Ziegler S, Waldmann H (2019) Inhibition of glucose transporters and glutaminase synergistically impairs tumor cell growth. Cell Chem Biol 26(9):1214–1228. e1225. https://doi.org/10.1016/j.chembiol.2019.06.005
Reed MJ, Penn PE, Li Y, Birnbaum R, Vernon RB, Johnson TS, Pendergrass WR, Sage EH, Abrass IB, Wolf NS (1996) Enhanced cell proliferation and biosynthesis mediate improved wound repair in refed, caloric-restricted mice. Mech Ageing Dev 89(1):21–43. https://doi.org/10.1016/0047-6374(96)01737-x
Reelfs O, Abbate V, Cilibrizzi A, Pook MA, Hider RC, Pourzand C (2019) The role of mitochondrial labile iron in Friedreich’s ataxia skin fibroblasts sensitivity to ultraviolet A. Metallomics 11(3):656–665. https://doi.org/10.1039/c8mt00257f
Reelfs O, Tyrrell RM, Pourzand C (2004) Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-kappaB in human skin fibroblasts. J Invest Dermatol 122(6):1440–1447. https://doi.org/10.1111/j.0022-202X.2004.22620.x
Reis LMD, Adamoski D, Ornitz Oliveira Souza R, Rodrigues Ascencao CF, Sousa de Oliveira KR, Correa-da-Silva F, Malta de Sa Patroni F, Meira Dias M, Consonni SR, Mendes de Moraes-Vieira PM, Silber AM, SMG D (2019) Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells. J Biol Chem 294(24):9342–9357. https://doi.org/10.1074/jbc.RA119.008180
Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R (1994) Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 54(18):4848–4850
Rieger J, Bahr O, Maurer GD, Hattingen E, Franz K, Brucker D, Walenta S, Kammerer U, Coy JF, Weller M, Steinbach JP (2014) ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44(6):1843–1852. https://doi.org/10.3892/ijo.2014.2382
Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J (1996) Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 23(12):1641–1674. https://doi.org/10.1007/bf01249629
Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, Gonzalez MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A (2004) Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J 23(2):115–118
Robertson JM, Sondak VK, Weiss SA, Sussman JJ, Chang AE, Lawrence TS (1995) Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 31(1):87–92. https://doi.org/10.1016/0360-3016(94)00341-h
Ronchi JA, Francisco A, Passos LAC, Figueira TR, Castilho RF (2016) The contribution of nicotinamide nucleotide transhydrogenase to peroxide detoxification is dependent on the respiratory state and counterbalanced by other sources of NADPH in liver mitochondria. J Biol Chem 291(38):20173–20187. https://doi.org/10.1074/jbc.M116.730473
Rous P (1914) The influence of diet on transplanted and spontaneous mouse tumors. J Exp Med 20(5):433–451. https://doi.org/10.1084/jem.20.5.433
Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW (1989) Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res 49(15):4130–4134
Sabatini DM (2017) Twenty-five years of mTOR: uncovering the link from nutrients to growth. Proc Natl Acad Sci U S A 114(45):11818–11825. https://doi.org/10.1073/pnas.1716173114
Saif MW, Berk G, Cheng YC, Kinsella TJ (2007) IPdR: a novel oral radiosensitizer. Expert Opin Investig Drugs 16(9):1415–1424. https://doi.org/10.1517/13543784.16.9.1415
Saxton RA, Sabatini DM (2017) mTOR Signaling in growth, metabolism, and disease. Cell 168(6):960–976. https://doi.org/10.1016/j.cell.2017.02.004
Schirch V, Szebenyi DM (2005) Serine hydroxymethyltransferase revisited. Curr Opin Chem Biol 9(5):482–487. https://doi.org/10.1016/j.cbpa.2005.08.017
Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Shanahan Kauffman EP, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG (2017) O2(−) and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell 31(4):487–500. e488. https://doi.org/10.1016/j.ccell.2017.02.018
Schwartz KA, Noel M, Nikolai M, Chang HT (2018) Investigating the ketogenic diet as treatment for primary aggressive brain cancer: challenges and lessons learned. Front Nutr 5:11. https://doi.org/10.3389/fnut.2018.00011
Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW (2007) Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 298(19):2289–2295. https://doi.org/10.1001/jama.298.19.2289
Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P (2003) Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br J Cancer 89(7):1375–1382. https://doi.org/10.1038/sj.bjc.6601269
Shewach DS, Hahn TM, Chang E, Hertel LW, Lawrence TS (1994) Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res 54(12):3218–3223
Shibata S, Satake N, Hester RK, Kurahashi K, Ito M (1988) The mode of vasoinhibitory action of a pyridazione derivative (MCI-154), a new cardiotonic agent, on contractile responses induced by alpha-adrenoceptor agonists and 45Ca influx in isolated vascular smooth muscles. Eur J Pharmacol 145(2):113–121. https://doi.org/10.1016/0014-2999(88)90222-1
Shibuya K, Okada M, Suzuki S, Seino M, Seino S, Takeda H, Kitanaka C (2015) Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells. Oncotarget 6(2):651–661. https://doi.org/10.18632/oncotarget.2892
Silva B, Faustino P (2015) An overview of molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta 1852(7):1347–1359. https://doi.org/10.1016/j.bbadis.2015.03.011
Silverstone H, Tannenbaum A (1951) Proportion of dietary protein and the formation of spontaneous hepatomas in the mouse. Cancer Res 11(6):442–446
Singh D, Banerji AK, Dwarakanath BS, Tripathi RP, Gupta JP, Mathew TL, Ravindranath T, Jain V (2005) Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme. Strahlenther Onkol 181(8):507–514. https://doi.org/10.1007/s00066-005-1320-z
Soderlund K, Perez-Tenorio G, Stal O (2005) Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells. Int J Oncol 26(1):25–32
Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, Kang Y, Fleming JB, Bardeesy N, Asara JM, Haigis MC, DePinho RA, Cantley LC, Kimmelman AC (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496(7443):101–105. https://doi.org/10.1038/nature12040
Speers C, Feng FY, Pierce LJ (2014) PARP-1 inhibitors and radiotherapy sensitivity: future prospects for therapy? Breast Cancer Management 3(3):281–296. https://doi.org/10.2217/bmt.14.6
Spitz DR, Sim JE, Ridnour LA, Galoforo SS, Lee YJ (2000) Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci 899:349–362. https://doi.org/10.1111/j.1749-6632.2000.tb06199.x
Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV (2015) MYC, metabolism, and cancer. Cancer Discov 5(10):1024–1039. https://doi.org/10.1158/2159-8290.CD-15-0507
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330
Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404(6773):42–49. https://doi.org/10.1038/35003506
Tateishi K, Wakimoto H, Iafrate AJ, Tanaka S, Loebel F, Lelic N, Wiederschain D, Bedel O, Deng G, Zhang B, He T, Shi X, Gerszten RE, Zhang Y, Yeh J-RJ, Curry WT, Zhao D, Sundaram S, Nigim F, Koerner MVA, Ho Q, Fisher DE, Roider EM, Kemeny LV, Samuels Y, Flaherty KT, Batchelor TT, Chi AS, Cahill DP (2015) Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion. Cancer Cell 28(6):773–784. https://doi.org/10.1016/j.ccell.2015.11.006
Tisdale MJ, Brennan RA, Fearon KC (1987) Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer 56(1):39–43. https://doi.org/10.1038/bjc.1987.149
Torti SV, Torti FM (2011) Ironing out cancer. Cancer Res 71(5):1511–1514. https://doi.org/10.1158/0008-5472.CAN-10-3614
Turcan S, Makarov V, Taranda J, Wang Y, Fabius AWM, Wu W, Zheng Y, El-Amine N, Haddock S, Nanjangud G, LeKaye HC, Brennan C, Cross J, Huse JT, Kelleher NL, Osten P, Thompson CB, Chan TA (2018) Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence. Nat Genet 50(1):62–72. https://doi.org/10.1038/s41588-017-0001-z
Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AW, Lu C, Ward PS, Thompson CB, Kaufman A, Guryanova O, Levine R, Heguy A, Viale A, Morris LG, Huse JT, Mellinghoff IK, Chan TA (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483(7390):479–483. https://doi.org/10.1038/nature10866
Vander Heiden MG (2011) Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10(9):671–684. https://doi.org/10.1038/nrd3504
Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49(23):6449–6465
Visentin M, Zhao R, Goldman ID (2012) The antifolates. Hematol Oncol Clin North Am 26(3):629–6ix. https://doi.org/10.1016/j.hoc.2012.02.002
Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol 21(14):2636–2644. https://doi.org/10.1200/jco.2003.11.136
Vogl DTYA, Stewart K, Orford KW, Bennett M, Siegel D, Berdeja JG (2015) Phase 1 study of CB-839, a first-in-class, glutaminase inhibitor in patients with multiple myeloma and lymphoma. Blood 126(23):3059
Wahl DR, Dresser J, Wilder-Romans K, Parsels JD, Zhao SG, Davis M, Zhao L, Kachman M, Wernisch S, Burant CF, Morgan MA, Feng FY, Speers C, Lyssiotis CA, Lawrence TS (2017) Glioblastoma therapy can be augmented by targeting IDH1-mediated NADPH biosynthesis. Cancer Res 77(4):960–970. https://doi.org/10.1158/0008-5472.can-16-2008
Wang B, Hasan MK, Alvarado E, Yuan H, Wu H, Chen WY (2011) NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene 30(8):907–921. https://doi.org/10.1038/onc.2010.468
Wang ES, Frankfurt O, Orford KW, Bennett M, Flinn IW, Maris M, Konopleva M (2015) Phase 1 study of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase in patients with relapsed/refractory leukemia. Blood 126(23):2566
Wang Y-C, Chiang E-PI (2012) Low-dose methotrexate inhibits methionine S-adenosyltransferase in vitro and in vivo. Mol Med 18(1):423–432. https://doi.org/10.2119/molmed.2011.00048
Warburg O (1924) Uber den Stoffwechsel der Carcinomzelle. 12. https://doi.org/10.1007/BF01504608
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309–314. https://doi.org/10.1126/science.123.3191.309
Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, Rabinowitz JD, Carroll M, Su SM, Sharp KA, Levine RL, Thompson CB (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17(3):225–234. https://doi.org/10.1016/j.ccr.2010.01.020
Wardman P, Candeias LP (1996) Fenton chemistry: an introduction. Radiat Res 145(5):523–531
Weindruch R, Naylor PH, Goldstein AL, Walford RL (1988) Influences of aging and dietary restriction on serum thymosin alpha 1 levels in mice. J Gerontol 43(2):B40–B42. https://doi.org/10.1093/geronj/43.2.b40
Welsh JL, Wagner BA, van't Erve TJ, Zehr PS, Berg DJ, Halfdanarson TR, Yee NS, Bodeker KL, Du J, Roberts LJ 2nd, Drisko J, Levine M, Buettner GR, Cullen JJ (2013) Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol 71(3):765–775. https://doi.org/10.1007/s00280-013-2070-8
Wen B, Deutsch E, Marangoni E, Frascona V, Maggiorella L, Abdulkarim B, Chavaudra N, Bourhis J (2001) Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells. Br J Cancer 85(12):2017–2021. https://doi.org/10.1054/bjoc.2001.2171
Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, Jager PL, Van Eck-Smit BL, Plukker JT, van Lanschot JJ, Sloof GW (2005) Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy—systematic review. Radiology 236(3):841–851. https://doi.org/10.1148/radiol.2363041042
Wheless JW (2004) History and origin of the ketogenic diet. In: Stafstrom CE, Rho JM (eds) Epilepsy and the ketogenic diet. Humana Press, Totowa, NJ, pp 31–50
Ye J, Fan J, Venneti S, Wan Y-W, Pawel BR, Zhang J, Finley LWS, Lu C, Lindsten T, Cross JR, Qing G, Liu Z, Simon MC, Rabinowitz JD, Thompson CB (2014) Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov 4(12):1406–1417. https://doi.org/10.1158/2159-8290.cd-14-0250
Ying W (2008) NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10(2):179–206. https://doi.org/10.1089/ars.2007.1672
Yuan TL, Cantley LC (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27(41):5497–5510. https://doi.org/10.1038/onc.2008.245
Zahra A, Fath MA, Opat E, Mapuskar KA, Bhatia SK, Ma DC, Rodman SN III, Snyders TP, Chenard CA, Eichenberger-Gilmore JM, Bodeker KL, Ahmann L, Smith BJ, Vollstedt SA, Brown HA, Hejleh TA, Clamon GH, Berg DJ, Szweda LI, Spitz DR, Buatti JM, Allen BG (2017) Consuming a ketogenic diet while receiving radiation and chemotherapy for locally advanced lung cancer and pancreatic cancer: the University of Iowa experience of two phase 1 clinical trials. Radiat Res 187(6):743–754. https://doi.org/10.1667/RR14668.1
Zhang D, Ochi N, Takigawa N, Tanimoto Y, Chen Y, Ichihara E, Hotta K, Tabata M, Tanimoto M, Kiura K (2011) Establishment of pemetrexed-resistant non-small cell lung cancer cell lines. Cancer Lett 309(2):228–235. https://doi.org/10.1016/j.canlet.2011.06.006
Zhang Q (2018) It takes two to tango: IDH mutation and glutaminase inhibition in glioma. Sci Transl Med 10(460):344. https://doi.org/10.1126/scitranslmed.aav0344
Zhao H, Zheng GH, Li GC, Xin L, Wang YS, Chen Y, Zheng XM (2019) Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer. J Cell Physiol 234(12):23349–23359. https://doi.org/10.1002/jcp.28902
Zhao Y, Butler EB, Tan M (2013) Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis 4:e532. https://doi.org/10.1038/cddis.2013.60
Zhao Y, Liu H, Liu Z, Ding Y, Ledoux SP, Wilson GL, Voellmy R, Lin Y, Lin W, Nahta R, Liu B, Fodstad O, Chen J, Wu Y, Price JE, Tan M (2011) Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res 71(13):4585–4597. https://doi.org/10.1158/0008-5472.CAN-11-0127
Zhong JL, Yiakouvaki A, Holley P, Tyrrell RM, Pourzand C (2004) Susceptibility of skin cells to UVA-induced necrotic cell death reflects the intracellular level of labile iron. J Invest Dermatol 123(4):771–780. https://doi.org/10.1111/j.0022-202X.2004.23419.x
Zhou S, Kachhap S, Sun W, Wu G, Chuang A, Poeta L, Grumbine L, Mithani SK, Chatterjee A, Koch W, Westra WH, Maitra A, Glazer C, Carducci M, Sidransky D, McFate T, Verma A, Califano JA (2007) Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci U S A 104(18):7540–7545. https://doi.org/10.1073/pnas.0610818104
Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P, Seyfried TN (2010) Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report. Nutr Metab (Lond) 7:33. https://doi.org/10.1186/1743-7075-7-33
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wahl, D., Petronek, M., Ramachandran, R., Floberg, J., Allen, B.G., Schwarz, J.K. (2020). Targeting Tumor Metabolism to Overcome Radioresistance. In: Willers, H., Eke, I. (eds) Molecular Targeted Radiosensitizers. Cancer Drug Discovery and Development. Humana, Cham. https://doi.org/10.1007/978-3-030-49701-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-49701-9_10
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-49700-2
Online ISBN: 978-3-030-49701-9
eBook Packages: MedicineMedicine (R0)